Sensitization of adenylate cyclase by Gαi/o-coupled receptors

Pharmacology and Therapeutics

Volumn 106, Issue 3, 2005, Pages 405-421

  Watts, Val J ^a   Neve, Kim A ^b  

^a PURDUE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Adenylate cyclase; Drug abuse; G proteins; Heterologous sensitization; Superactivation

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPROTEIN; PROTEIN KINASE;

DESENSITIZATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; NERVE CELL; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SENSITIZATION;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MODELS, BIOLOGICAL; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 19444378697     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2004.12.005     Document Type: Review

References (154)

1. H. Ammer, and T.E. Christ Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity J Neurochem 83 2002 818 827
2. 1 receptor system in neuroblastoma×glioma (NG108-15) hybrid cells J Neurochem 64 1995 2449 2457
3. 1 receptors and stimulatory G proteins Brain Res 707 1996 235 244
4. sα Mol Pharmacol 52 1997 993 999
5. sα subunit J Pharmacol Exp Ther 286 1998 855 862
6. H. Ammer, and R. Schulz Opioid tolerance/dependence in neuroblastoma×glioma (NG108-15) hybrid cells is associated with a reduction in spontaneous stimulatory receptor activity FEBS Lett 485 2000 157 162
7. S.M. Anderson, and R.C. Pierce Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement Pharmacol Ther 2005
8. T. Avidor-Reiss, M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, and Z. Vogel Adenylylcyclase supersensitization in m-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment J Biol Chem 270 1995 29732 29738
9. βγ J Biol Chem 271 1996 21309 21315
10. T. Avidor-Reiss, I. Nevo, D. Saya, M. Bayewitch, and Z. Vogel Opiate-induced adenylyl cyclase superactivation is isozyme-specific J Biol Chem 272 1997 5040 5047
11. B. Banihashemi, and P.R. Albert Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Gα and Gβγ requirements Mol Endocrinol 16 2002 2393 2404
12. M. Bastepe, Y. Gunes, B. Perez-Villamil, J. Hunzelman, L.S. Weinstein, and H. Juppner Receptor-mediated adenylyl cyclase activation through XLαs, the extra-large variant of the stimulatory G protein α-subunit Mol Endocrinol 16 2002 1912 1919
13. 2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization Mol Pharmacol 39 1991 55 63
14. i/o-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation Mol Pharmacol 57 2000 820 825
15. 2L dopamine receptor-mediated sensitization of adenylate cyclase type 6 Cell Signal 17 2005 647 653
16. M.A. Beazely, J.K. Alan, and V.J. Watts Protein Kinase C and epidermal growth factor stimulation of Raf1 potentiates AC6 activation in intact cells Mol Pharmacol 67 2005 250 259
17. J.A. Bibb, J. Chen, J.R. Taylor, P. Svenningsson, A. Nishi, and G.L. Snyder Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 Nature 410 2001 376 380
18. L.M. Bohn, R.R. Gainetdinov, R.-T. Lin, R.J. Lefkowitz, and M.G. Caron μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence Nature 408 2000 720 723
19. 2+ responses in CHO-K1 cells FEBS Lett 533 2003 67 71
20. M.S. Bowers, K. McFarland, R.W. Lake, Y.K. Peterson, C.C. Lapish, and M.L. Gregory Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking Neuron 42 2004 269 281
21. K.C. Bradley, and R.L. Meisel Sexual behavior induction of c-Fos in the nucleus accumbens and amphetamine-stimulated locomotor activity are sensitized by previous sexual experience in female Syrian hamsters J Neurosci 21 2001 2123 2130
22. K.C. Bradley, A.J. Mullins, R.L. Meisel, and V.J. Watts Sexual experience alters D1 receptor-mediated cyclic AMP production in the nucleus accumbens of female Syrian hamsters Synapse 53 2004 20 27
23. S. Chakrabarti, L. Wang, W.-J. Tang, and A.R. Gintzler Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence Mol Pharmacol 54 1998 949 953
24. sα stimulation of adenylyl cyclase: relevance to opioid tolerance Mol Pharmacol 54 1998 655 662
25. αi3 J Neurochem 74 2000 1068 1078
26. T.K. Chatterjee, A.K. Eapen, and R.A. Fisher A truncated form of RGS3 negatively regulates G protein-coupled receptor stimulation of adenylyl cyclase and phosphoinositide phospholipase C J Biol Chem 272 1997 15481 15487
27. s) and adenylyl cyclase J Neurochem 64 1995 724 732
28. J. Chen, and M.M. Rasenick Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content J Pharmacol Exp Ther 275 1995 509 517
29. s stimulation Proc Natl Acad Sci USA 94 1997 14100 14104
30. J.A. Chester, A.J. Mullins, C.H. Nguyen, V.J. Watts, and R.L. Meisel Effects of chronic quinpirole on behavioral and neurochemical sensitization in female hamsters Soc Neurosci Abstr 30 2004 (program no. 466.19)
31. E.-J. Choi, W.T. Wong, T.R. Hinds, and D.R. Storm Calcium and muscarinic agonist stimulation of type I adenylylcyclase in whole cells J Biol Chem 267 1992 12440 12442
32. M.J. Cismowski, A. Takesono, C. Ma, J.S. Lizano, X. Xie, and H. Fuernkranz Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling Nature Biotechnol 17 1999 878 883
33. M.J. Cismowski, C. Ma, C. Ribas, X. Xie, M. Spruyt, and J.S. Lizano Activation of heterotrimeric G-protein signaling by a Ras-related protein. Implications for signal integration J Biol Chem 275 2000 23421 23424
34. M.J. Cismowski, A. Takesono, M.L. Bernard, E. Duzic, and S.M. Lanier Receptor-independent activators of heterotrimeric G-proteins Life Sci 68 2001 2301 2308
35. D.E. Clapham, and E.J. Neer G protein βγ subunits Annu Rev Pharmacol Toxicol 37 1997 167 203
36. o-dependent, μ-opioid agonist-mediated adenylyl cyclase supersensitization J Pharmacol Exp Ther 310 2004 215 222
37. 2 dopamine receptors J Pharmacol Exp Ther 297 2001 1201 1209
38. K.E. Culm, N. Lugo-Escobar, B.T. Hope, and R.P. Hammer Jr. Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats Neuropsychopharmacology 10 2004 1823 1830
39. M.G. Cumbay, and V.J. Watts Novel regulatory properties of human type 9 adenylate cyclase (AC9) J Pharmacol Exp Ther 310 2004 108 115
40. M.A. DeBernardi, R. Munshi, A. Yoshimura, D.M.F. Cooper, and G. Brooker Predominant expression of Type VI adenylyl cyclase in rat C6-2B glioma cells may account for calcium inhibition of cAMP accumulation Biochem J 295 1993 325 328
41. N. Defer, M. Best-Belpomme, and J. Hanoune Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase Am J Physiol Renal Physiol 279 2000 F400 F416
42. P.R. DiBello, T.R. Garrison, D.M. Apanovitch, G. Hoffman, D.J. Shuey, and K. Mason Selective uncoupling of RGS action by a single point mutation in the G protein α-subunit J Biol Chem 273 1998 5780 5784
43. Q. Ding, R. Gros, I.D. Gray, R. Taussig, S.S. Ferguson, and R.D. Feldman Raf kinase activation of adenylyl cyclases: isoform-selective regulation Mol Pharmacol 66 2004 921 928
44. S.S. Ferguson Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling Pharmacol Rev 53 2001 1 24
45. A.A. Fienberg, N. Hiroi, P.G. Mermelstein, W. Song, G.L. Snyder, and A. Nishi DARPP-32: regulator of the efficacy of dopaminergic neurotransmission Science 281 1998 838 842
46. A.K. Finn, and J.L. Whistler Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal Neuron 32 2001 829 839
47. S. Freduduzzi, R. Moratalla, A. Monopoli, B. Cuellar, K. Xu, and E. Ongini Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors J Neurosci 22 2002 1054 1062
48. K. Fuxe, I. Stromberg, P. Popoli, R. Rimondini-Giorgini, M. Torvinen, and S.O. Ogren Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum Adv Neurol 86 2001 345 353
49. R.R. Gainetdinov, R.T. Premont, L.M. Bohn, R.J. Lefkowitz, and M.G. Caron Desensitization of G protein-coupled receptors and neuronal functions Annu Rev Neurosci 27 2004 107 144
50. A.S. Gordon, L. Yao, Z. Jiang, C.S. Fishburn, S. Fuchs, and I. Diamond Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C Mol Pharmacol 59 2001 153 160
51. i-coupled formyl peptide receptor to Erk-1/2 MAP kinases J Biol Chem 277 2002 10876 10882
52. B.M. Hacker, J.E. Tomlinson, G.A. Wayman, R. Sultana, G. Chan, and E. Villacres Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9) Genomics 50 1998 97 104
53. J.R. Hadcock, and C.C. Malbon Agonist regulation of gene expression of adrenergic receptors and G proteins J Neurochem 60 1993 1 9
54. A. Harry, Y.B. Chen, R. Magnusson, R. Iyengar, and G.Z. Weng Differential regulation of adenylyl cyclases by Gas J Biol Chem 272 1997 19017 19021
55. D.G. Hazlerigg, A. Gonzalez-Brito, W. Lawson, M.H. Hastings, and P.J. Morgan Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary Endocrinology 132 1993 285 292
56. K. Hellevuo, M. Yoshimura, M. Kao, P.L. Hoffman, D.M.F. Cooper, and B. Tabakoff A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line Biochem Biophys Res Comm 192 1993 311 318
57. J. Hillion, M. Canals, M. Torvinen, V. Casado, R. Scott, and A. Terasmaa Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors J Biol Chem 277 2002 18091 18097
58. q-mediated signaling by expression of RGS4 or GAIP in mammalian cells Proc Natl Acad Sci USA 94 1997 6159 6163
59. G. Iwami, J.-I. Kawabe, T. Ebina, P.J. Cannon, C.J. Homey, and Y. Ishikawa Regulation of adenylyl cyclase by protein kinase A J Biol Chem 270 1995 12481 12484
60. O. Jacobowitz, and R. Iyengar Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2 Proc Natl Acad Sci USA 91 1994 10630 10634
61. M. Jiang, K. Spicher, G. Boulay, Y. Wang, and L. Birnbaumer Most central nervous system D2 dopamine receptors are coupled to their effectors by Go Proc Natl Acad Sci USA 98 2001 3577 3582
62. i/o-coupled receptors? Life Sci 73 2003 2913 2925
63. 2L cells FEBS Lett 497 2001 85 89
64. 2L cells J Neurochem 82 2002 1087 1096
65. C.A. Johnston, M.A. Beazely, M.L. Bilodeau, O.M. Andrisani, and V.J. Watts Differentiation-induced alterations in cyclic AMP signaling in the Cath.a Differentiated (CAD) neuronal cell line J Neurochem 88 2004 1497 1508
66. 3H]forskolin binding in membranes from HT29 cells Biochem Pharmacol 40 1990 871 877
67. 2- Adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production Proc Natl Acad Sci USA 84 1987 1294 1298
68. M.B. Jones, D.P. Siderovski, and S.B. Hooks The Gβγ dimer as a novel source of selectivity in G-protein signaling: GGL-ing at convention Mol Interv 4 2004 200 214
69. M.B. Kelz, J. Chen, W.A.J. Carlezon, K. Whisler, L. Gilden, and A.M. Beckmann Expression of the transcription factor DFosB in the brain controls sensitivity to cocaine Nature 401 1999 272 276
70. S.A. Kotecha, J.N. Oak, M.F. Jackson, Y. Perez, B.A. Orser, and H.H.M. Van Tol A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission Neuron 35 2002 1111 1122
71. H.-L. Lai, R.-T. Lin, M. Kao, W.-J. Lin, M.-J. Hwang, and Y. Chern The N terminus domain of type VI adenylyl cyclase mediates its inhibition by protein kinase C Mol Pharmacol 56 1999 644 650
72. o and Gαi1 blocks interactions with RGS proteins FASEB 12 1998 A124
73. S.B. Lane-Ladd, J. Pineda, V.A. Boundy, T. Pfeuffer, J. Krupinski, and G.K. Aghajanian CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence J Neurosci 17 1997 7890 7901
74. J.G. Li, F. Zhang, X.L. Jin, and L.Y. Liu-Chen Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation J Pharmacol Exp Ther 305 2003 531 540
75. T.-H. Lin, H.-L. Lai, Y.-Y. Kao, C.-N. Sun, M.-J. Hwang, and Y. Chern Protein kinase C inhibits type VI adenylyl cyclase by phosphorylating the regulatory N domain and two catalytic C1 and C2 domains J Biol Chem 277 2002 15721 15728
76. J.G. Lisinicchia, and V.J. Watts Sensitization of adenylate cyclase by short-term activation of 5-HT1A receptors Cell Signal 15 2003 1111 1117
77. F.-C. Liu, G.-C. Wu, S.-T. Hsieh, H.-L. Lai, H.-F. Wang, and T.-W. Wang Expression of type VI adenylyl cyclase in the central nervous system: implication for a potential regulator of multiple signals in different neurotransmitter systems FEBS Lett 436 1998 92 98
78. βγ-subunits in Balb/c-3T3 cells Am J Physiol Cell Physiol 284 2003 C640 C648
79. L.Y. Liu-Chen Agonist-induced regulation and trafficking of kappa opioid receptors Life Sci 75 2004 511 536
80. A. Marjamaki, M. Sato, R. Bouet-Alard, Q. Yang, I. Limon-Boulez, and C. Legrand Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors - Integration of stimulatory and inhibitory input to the effector adenylyl cyclase J Biol Chem 272 1997 16466 16473
81. R.L. Meisel, M.A. Joppa, and R.K. Rowe Dopamine receptor antagonists attenuate conditioned place preference following sexual behavior in female Syrian hamster Eur J Pharmacol 309 1996 21 24
82. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nature Rev 2 2001 119 128
83. E.J. Nestler Historical review: molecular and cellular mechanisms of opiate and cocaine addiction Trends Pharmacol Sci 25 2004 210 218
84. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 62
85. E.J. Nestler, and J.F. Tallman Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus Mol Pharmacol 33 1988 127 132
86. E.J. Nestler, M. Alreja, and G.K. Aghajanian Molecular control of locus coeruleus neurotransmission Biol Psych 46 1999 1131 1139
87. R.R. Neubig, and D.P. Siderovski Regulators of G-protein signalling as new central nervous system drug targets Nature Rev 1 2002 187 197
88. J.F. Neumaier, T.J. Sexton, J. Yracheta, A.M. Diaz, and M. Brownfield Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression J Chem Neuroanat 21 2001 63 73
89. I. Nevo, T. Avidor-Reiss, R. Levy, M. Bayewitch, E. Heldman, and Z. Vogel Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors Mol Pharmacol 54 1998 419 426
90. I. Nevo, T. Avidor-Reiss, R. Levy, M. Bayewitch, and Z. Vogel Acute and chronic activation of the m-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes Neuropharmacology 39 2000 364 371
91. 2L receptor stimulation of the mitogen-activated protein kinase pathway is dependent on trans-activation of the platelet-derived growth factor receptor Mol Pharmacol 60 2001 92 103
92. R.S. Ostrom, S.R. Post, and P.A. Insel Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving GS J Pharmacol Exp Ther 294 2000 407 412
93. R.S. Ostrom, C. Gregorian, R.M. Drenan, Y. Xiang, and J.W. Regan Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase J Biol Chem 276 2001 42063 42069
94. 3 adenosine receptor Mol Pharmacol 52 1997 632 640
95. T.B. Patel, Z. Du, S. Pierre, L. Cartin, and K. Scholich Molecular biological approaches to unravel adenylyl cyclase signaling and function Gene 269 2001 13 25
96. 2+/calcineurin and differential mRNA polyadenylation J Neurochem 75 2000 1358 1367
97. R.C. Pierce, and P.W. Kalivas A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants Brain Res Brain Res Rev 25 1997 192 216
98. R. Qanbar, and M. Bouvier Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function Pharmacol Ther 97 2003 1 33
99. T.D. Reisine, and J.S. Takahashi Somatostatin pretreatment desensitizes somatostatin receptors linked to adenylate cyclase and facilitates the stimulation of cyclic adenosine 3′:5′:monophosphate accumulation in anterior pituitary tumor cells J Neurosci 4 1984 812 819
100. C. Reithmann, and K. Werdan Chronic muscarinic cholinoceptor stimulation increases adenylyl cyclase responsiveness in rat cardiomyocytes by a decrease in the level of inhibitory G-protein a-subunits Naunyn-Schmiedeber's Arch Pharmacol 351 1995 27 34
101. 1 cannabinoid receptor Mol Pharmacol 57 2000 746 752
102. M. Rubenzik, E. Varga, D. Stropova, W.R. Roeske, and H.I. Yamamura Expression of α-transducin in Chinese hamster ovary cells stably transfected with the human δ-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation Mol Pharmacol 60 2001 1076 1082
103. S. Salim, S. Sinnarajah, J.H. Kehrl, and C.W. Dessauer Identification of RGS2 and type V adenylyl cyclase interaction sites J Biol Chem 278 2003 15842 25849
104. i J Biol Chem 279 2004 13375 13382
105. A.N.M. Schoffelmeer, P. Voorn, A.J. Jonker, G. Wardeh, P. Nestby, and L.J.M.J. Vanderschuren Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization Neurochem Res 21 1996 1417 1423
106. A.N.M. Schoffelmeer, T.J. De Vries, L.J.M.J. Vanderschuren, G.H.K. Tjon, P. Nestby, and G. Warden Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons Synapse 25 1997 381 388
107. K. Scholich, J.B. Mullenix, C. Wittpoth, H.M. Poppleton, S.C. Pierre, and M.A. Lindorfer Facilitation of signal onset and termination by adenylyl cyclase Science 283 1999 1328 1331
108. D.W. Self, L.M. Genova, B.T. Hope, W.J. Barnhart, J.J. Spencer, and E.J. Nestler Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior J Neurosci 18 1998 1848 1859
109. S.K. Sharma, W.A. Klee, and M. Nirenberg Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance Proc Natl Acad Sci USA 72 1975 3092 3096
110. S. Sinnarajah, C.W. Dessauer, D. Srikumar, J. Chen, J. Yuen, and S. Yilma RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III Nature 409 2001 1051 1055
111. P.C. Sternweis, and J.D. Robishaw Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain J Biol Chem 259 1984 13806 13813
112. R.K. Sunahara, and R. Taussig Isoforms of mammalian adenylyl cyclase: multiplicities of signaling Mol Interv 2 2002 168 184
113. A. Takesono, M.J. Cismowski, C. Ribas, M. Bernard, P. Chung, and S. Hazard III Receptor-independent activators of heterotrimeric G-protein signaling pathways J Biol Chem 274 1999 33202 33205
114. A. Takesono, M.W. Nowak, M.J. Cismowski, E. Duzic, and S.M. Lanier Activator of G-protein signaling 1 blocks GIRK channel activation by a G protein-coupled receptor J Biol Chem 277 2002 13827 13830
115. C.M. Tan, D.J. Kelvin, D.W. Litchfield, S.S.G. Ferguson, and R.D. Feldman Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase Biochemistry 40 2001 1702 1709
116. W.-J. Tang, and A.G. Gilman Type-specific regulation of adenylyl cyclase by G protein bg subunits Science 254 1991 1500 1502
117. R. Taussig, and G. Zimmerman Type-specific regulation of mammalian adenylyl cyclases by G protein pathways Adv Second Messenger Phosphoprotein Res 32 1998 81 98
118. R. Taussig, S. Sanchez, M. Rifo, and A.G. Gilman Inhibition of the ω-conotoxin-sensitive calcium current by distinct G proteins Neuron 8 1992 799 809
119. R. Taussig, L.M. Quarmby, and A.G. Gilman Regulation of purified type I and type II adenylylcyclases by G protein βγ subunits J Biol Chem 268 1993 9 12
120. J.M. Thomas, and B.B. Hoffman Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists? Trends Pharmacol Sci 8 1987 308 311
121. J.M. Thomas, and B.B. Hoffman Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants Mol Pharmacol 35 1989 116 124
122. J.M. Thomas, and B.B. Hoffman Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform Mol Pharmacol 49 1996 907 914
123. sα from plasma membrane J Neurochem 73 1999 1114 1120
124. Z can mediate the acute actions of μ- and κ-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization J Pharmacol Exp Ther 295 2000 168 176
125. i2 in opioid-induced adenylyl cyclase supersensitization Mol Neurosci 11 2000 3213 3217
126. i3 Neurosci Lett 299 2001 25 28
127. Z following acute and chronic activation of the δ-opioid receptor J Neurochem 74 2000 1685 1693
128. 2+ concentration decrease in GH4C1 cells J Biol Chem 265 1990 10320 10326
129. E.V. Varga, D. Stropova, M. Rubenzik, M. Wang, R.S. Landsman, and W.R. Roeske Identification of adenylyl cyclase isoenzymes in CHO and B82 cells Eur J Pharmacol 348 1998 R1 R2
130. E. Varga, D. Stropova, M. Rubenzik, S. Waite, W.R. Roeske, and H.I. Yamamura Phosphorylation of adenylyl cyclase VI upon chronic δ-opioid receptor stimulation Eur J Pharmacol 364 1999 R1 R3
131. E.V. Varga, M. Rubenzik, V. Grife, M. Sugiyama, D. Stropova, and W.R. Roeske Involvement of Raf-1 in chronic δ-opioid receptor agonist-mediated adenylyl cyclase superactivation Eur J Pharmacol 451 2002 101 102
132. E. Varga, M.K. Rubenzik, D. Stropova, M. Sugiyama, V. Grife, and V.J. Hruby Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic δ-opioid agonist treatment J Pharmacol Exp Ther 306 2003 109 115
133. E.V. Varga, H.I. Yamamura, M.K. Rubenzik, D. Stropova, E. Navratilova, and W.R. Roeske Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment Life Sci 74 2003 299 311
134. C. von Gall, M.L. Garabette, C.A. Kell, S. Frenzel, F. Dehghani, and P.M. Schumm-Draeger Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin Nat Neurosci 5 2002 234 238
135. 2 dopamine receptor activation J Pharmacol Exp Ther 308 2004 221 227
136. s in sensitization of AC1 J Biol Chem 66 2004 1617 1624
137. i-mediated cell signaling J Biol Chem 277 2002 48325 48332
138. Y. Wang, J.G. Li, P. Huang, W. Xu, and L.Y. Liu-Chen Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation J Pharmacol Exp Ther 307 2003 1127 1134
139. V.J. Watts Molecular mechanisms for heterologous sensitization of adenylate cyclase J Pharmacol Exp Ther 302 2002 1 7
140. 2 dopamine receptors Mol Pharmacol 50 1996 966 976
141. 3 dopamine receptors Mol Pharmacol 52 1997 181 186
142. 2L dopamine receptors in NS20Y neuroblastoma cells J Neurosci 18 1998 8692 8699
143. 4 dopamine receptors Psychopharmacology 141 1999 83 92
144. s: characterization of Gas-insensitive mutants of adenylyl cyclase V Mol Pharmacol 60 2001 1168 1172
145. M.E. Wolf Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways Molecular Interventions 2 2002 146 157
146. Y.H. Wong, B.R. Conklin, and H.R. Bourne Gz-Mediated hormonal inhibition of cyclic AMP accumulation Science 255 1992 339 342
147. 890 are involved in the functional properties of type VI adenylyl cyclase J Biol Chem 276 2001 35450 35457
148. Z. Xia, E.J. Choi, F. Wang, and D.R. Storm The type III calcium/calmodulin-sensitive adenylyl cyclase is not specific to olfactory sensory neurons Neurosci Lett 144 1992 169 173
149. t2) to inhibit forskolin-stimulated cAMP accumulation J Biol Chem 272 1997 16599 16602
150. 2 receptors J Neurosci 2000 5949 5957
151. X.F. Zhang, X.T. Hu, and F.J. White Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons J Neurosci 18 1998 488 498
152. s and sorting nexin in vesicular trafficking Science 294 2001 1939 1942
153. G. Zimmermann, and R. Taussig Protein kinase C alters the responsiveness of adenylyl cyclases to G protein α and βγ subunits J Biol Chem 271 1996 27161 27166
154. sα J Biol Chem 273 1998 6968 6975